Skip to content

Randomised trial, 2022

What research topics and methods have scientists focused on when studying PMS and PMDD?

Scientists have focused research on PMS and PMDD primarily through double-blind medication trials, with recent trends shifting toward understanding steroid hormone pathways and genetic factors.

Moderate study design Analysis of 100 most-cited research papers on PMS and PMDD published between 1999-2017

What they did

Researchers analyzed the 100 most-cited scientific papers on PMS and PMDD published between 1999 and 2017. They examined where and when these papers were published, which institutions led the research, and what topics the papers focused on using citation tracking software.

What they found

The 100 most-cited papers were published in 55 journals across 24 countries, with the US producing the most research. Top institutions were University of Pennsylvania, Yale, and the National Institute of Mental Health. Main research areas were obstetrics, gynecology, psychiatry, and reproductive biology. Most common topics were double-blind trials, fluoxetine and sertraline medications, efficacy, prevalence, depression, progesterone, and placebo. Recent trends focus on epidemiology, steroid hormone pathways, and genetics.

What it means for you

This analysis shows that scientists have historically focused on medications and controlled trials to understand PMS and PMDD. Newer research is exploring how hormones and genes affect symptoms. However, this analysis does not tell us whether any specific treatment actually works for PMS, as it only examines which research papers have been most influential.

100

most-cited papers analyzed

55

different journals represented

24

countries with published research

About the study

Original title
Top 100 Cited Papers on Premenstrual Syndrome/Premenstrual Dysphoric Disorder: A Bibliometric Study
Authors
Gao M, Zhang H, Wang C et al.
Journal
Frontiers in psychiatry
Year
2022
Study design
Randomised trial
What was tested
None, this is a review of other published research
Open access
Yes
Original abstract

Background: Premenstrual syndrome/premenstrual dysphoric disorder is a serious condition affecting women worldwide, causing clinically significant distress or interference. Therefore, solving these diseases has become the utmost concern worldwide, culminating in numerous studies. In this study, we performed bibliometric analysis on the 100 most cited papers with the aim of identifying research hot spots and trends in this field. Methods: We screened the Science Citation Index Expanded (SCIE) of Web of Science (WOS) to identify the top 100 cited studies on PMS/PMDD. Next, we analyzed relevant literature from various journals, countries/regions, institutions, authors, and keywords. Finally, we used VOSviewer and Citespace software to generate knowledge maps and identify hot spots and trends. Results: The top 100 highly cited studies were published in 55 journals, between 1999 and 2017, across 24 countries/regions around the world. Most articles were published in Obstetrics and Gynecology, whereas Psych neuroendocrinology had the largest average number of citations per paper. The United States had the highest number of publications, followed by England, Canada, and Sweden. The top three institutions that published the highly cited literature were the University of Pennsylvania, Yale University, and National Institute of Mental Health (NIMH). Obstetrics, Gynecology, Psychiatry, and Reproductive Biology were the main research directions, whereas the top 10 Co-occurrence of Keywords included double-blind, fluoxetine, efficacy, prevalence, epidemiology, phase sertraline treatment, depression, progesterone, placebo, and placebo-controlled trial. Results from cluster analysis indicated that more comprehensive epidemiology and steroid pathogenesis have gradually become the hot spots and trends. Conclusion: These findings demonstrated that bibliometric analysis can intuitively and rapidly reveal the frontiers and hot spots of research in PMS/PMDD. Notably, epidemiology, steroid pathogenesis, GABAA receptor delta subunits, and double-blind placebo-controlled trials are potential areas of focus for future research.

Reproduced under CC-BY.

Topics